Search

Your search keyword '"Pello, Ana"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Pello, Ana" Remove constraint Author: "Pello, Ana"
139 results on '"Pello, Ana"'

Search Results

1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

2. Serum Biomarkers and Their Association with Myocardial Function and Exercise Capacity in Cardiac Transthyretin Amyloidosis

4. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

5. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome

6. Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study

7. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.

8. The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study

9. Fibroblast Growth Factor 23 is a strong independent marker of worse cardiovascular outcomes after an acute coronary syndrome

12. TIME FOR A CHANGE: THE USE OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS IN ELDERLY PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AND CHRONIC KIDNEY DISEASE

13. IS SACUBITRIL/VALSARTAN LESS LIKELY TO BE PRESCRIBED IN ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION? A ROOT CAUSE ANALYSIS

14. Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

15. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

16. NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

17. USE AND BENEFIT OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITORS IN SENIOR PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

18. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

19. Abstract 11897: Prevalence of Abnormalities of Mineral Metabolism in Patients With Stable Coronary Artery Disease According to Renal Function

20. Abstract 11883: Mineral Metabolism Predictors of Poor Outcomes in Stable Coronary Artery Disease With and Without Impaired Renal Function

21. N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients

22. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

24. Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients

26. N-terminal Pro-brain Natriuretic Peptide plasma levels are Associated With a Short-Term Diagnosis of Cancer in Patients with Coronary Artery Disease

27. Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes

31. VALUE OF NT PROBNP IN THE PREDICTION OF CANCER IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

32. PROGNOSTIC VALUE OF PCSK9 AND LP(A) IN STABLE CORONARY ARTERY DISEASE

33. PROGNOSTIC VALUE OF HIGH SENSITIVE TROPONIN IN STABLE CORONARY ARTERY DISEASE

35. Los niveles plasmáticos elevados de TNF-R1 predicen el desarrollo de eventos isquémicos agudos en pacientes coronarios con diabetes

36. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial

37. Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

38. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

39. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

40. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors

41. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

42. Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

45. Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease

46. PATIENTS WITH CORONARY DISEASE WITHOUT TRADITIONAL RISK FACTORS SHOW A MORE FAVORABLE PROFILE OF BIOMARKERS RELATED TO MINERAL METABOLISM, INFLAMMATION AND HEART FAILURE

47. PARATHORMONE LEVELS ARE INDEPENDENTLY ASSOCIATED WITH THE PRESENCE OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH CORONARY ARTERY DISEASE

49. Design and rationale of amulticentre, randomised, double-blind, placebocontrolled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial

Catalog

Books, media, physical & digital resources